LEADERSHIP

Leadership

We are a small team of PhD scientists, and we run the work ourselves.

A NOTE ON THE NAME

BiocheMichael Industries now operates as Lodgepole Discovery. It is the same team and the same legal entity, and every agreement already in place stands unchanged.

Michael Holden

Michael Holden, PhD

FOUNDER · PROTEIN CHEMIST

PhD in Chemistry from the University of Denver, where his doctoral work was on tau fibrils. Contributed to IND-stage antibody programs at Prothena, antibody discovery at Regeneron, and built the antibody-to-ADC platform as Head of Chemistry at BioLoomics. Visiting Scholar at the University of Denver.

michael@lodgepolediscovery.com

Mike Minson

Mike Minson, PhD

SCIENTIST · ASSAYS

Cellular biochemist and molecular biologist with a PhD from the University of Colorado Boulder. Previously NGS assay design and validation for FDA submission at ArcherDx, antibody and exosome platform work at Sartorius, and synthetic biology lead at BioLoomics, running binding, internalization and killing assays across ADC discovery campaigns. He holds a selective Plasmidsaurus Fellowship for AI protein design.

mike@lodgepolediscovery.com

Doug Hattendorf

Doug Hattendorf, PhD

DIRECTOR · BUSINESS DEVELOPMENT

Protein scientist turned business builder, trained at the University of Chicago and Stanford. He ran protein bench science at Codexis and founded the enzyme engineering team at Zymergen, then moved to the commercial side, leading business development at Ginkgo Bioworks and GeneFab.

doug@lodgepolediscovery.com